PNC-28 (20mg) is a synthetic peptide derived from a mitochondrial targeting sequence of p53, designed to selectively induce apoptosis in cancerous cells. This peptide functions by disrupting mitochondrial membranes in malignant cells while sparing healthy tissues, making it a promising research tool for studies focused on cancer biology and targeted peptide therapeutics.
PNC-28 plays an important role in modulating pathways of apoptosis and cellular stress response, with demonstrated activity against various tumor cell lines. It has shown potential in reducing tumor growth, enhancing cellular clearance mechanisms, and restoring balance to tissue environments compromised by malignant transformation.
In addition to its antitumor effects, PNC-28 may contribute to improved immune recognition of abnormal cells and support systemic resilience against cancer progression. PNC-28 (20mg) offers a valuable compound for exploring therapeutic strategies related to oncology, apoptosis regulation, and cancer peptide research.
Alpha Biomed is not a compounding pharmacy or chemical compounding facility as defined under 503a of the federal food, drug, and cosmetic act. Alpha Biomed is not an outsourcing facility as defined under 503b of the federal food, drug, and cosmetic act.
Choosing a selection results in a full page refresh.
